Education
About Us
Working with TipRanks
Follow Us
Cormedix (CRMD)
NASDAQ:CRMD
Total Valuation
Cormedix has a market cap or net worth of $760.31M. The enterprise value is $951.35M.
Market Cap$760.31M
Enterprise Value$951.35M
Share Statistics
Cormedix has 78,789,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding78,789,050
Owned by Insiders2.18%
Owned by Institutions4.90%
Financial Efficiency
Cormedix’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -24.35%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-24.35%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee679.25K
Profits Per Employee-280.16K
Employee Count64
Asset Turnover0.37
Inventory Turnover0.42
Valuation Ratios
The current PE Ratio of Cormedix is 4.7. Cormedix’s PEG ratio is 0.40.
PE Ratio4.7
PS Ratio10.97
PB Ratio5.63
Price to Fair Value5.63
Price to FCF-9.40
Price to Operating Cash Flow<0.01
PEG Ratio0.40
Income Statement
In the last 12 months, Cormedix had revenue of 43.47M and earned -17.93M in profits. Earnings per share was -0.30.
Revenue43.47M
Gross Profit40.28M
Operating Income-22.36M
Pretax Income-19.32M
Net Income-17.93M
EBITDA-18.98M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was 74.97M and capital expenditures -549.76K, giving a free cash flow of 74.42M billion.
Operating Cash Flow74.97M
Free Cash Flow74.42M
Free Cash Flow per Share0.94
Dividends & Yields
Cormedix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.57
52-Week Price Change-2.13%
50-Day Moving Average10.95
200-Day Moving Average11.15
Relative Strength Index (RSI)37.13
Average Volume (3m)3.07M
Important Dates
Cormedix upcoming earnings date is Mar 31, 2026, TBA (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend Date―
Financial Position
Cormedix as a current ratio of 3.39, with Debt / Equity ratio of 39.80%
Current Ratio3.39
Quick Ratio3.16
Debt to Market Cap0.00
Net Debt to EBITDA2.13
Interest Coverage Ratio-614.10
Taxes
In the past 12 months, Cormedix has paid -1.39M in taxes.
Income Tax-1.39M
Effective Tax Rate0.07
Enterprise Valuation
Cormedix EV to EBITDA ratio is -23.19, with an EV/FCF ratio of -8.61.
EV to Sales10.05
EV to EBITDA-23.19
EV to Free Cash Flow-8.61
EV to Operating Cash Flow-8.63
Balance Sheet
Cormedix has $55.72M in cash and marketable securities with $148.92M in debt, giving a net cash position of -$93.20M billion.
Cash & Marketable Securities$55.72M
Total Debt$148.92M
Net Cash-$93.20M
Net Cash Per Share-$1.18
Tangible Book Value Per Share$1.41
Margins
Gross margin is 89.27%, with operating margin of -51.43%, and net profit margin of -41.24%.
Gross Margin89.27%
Operating Margin-51.43%
Pretax Margin-44.45%
Net Profit Margin-41.24%
EBITDA Margin-43.32%
EBIT Margin-44.37%
Analyst Forecast
The average price target for Cormedix is $18.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$18.40
Price Target Upside90.67% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast1647.67%
EPS Growth Forecast―